Galenea, Organix Inc., Case Western Reserve University, University of North Carolina, Tufts University School of Medicine deal

Galenea received exclusive, worldwide rights from Organix and the universities to develop and commercialize preclinical serotonin (5-HT2C) receptor agonists to treat obesity and related disorders. Or...